Browsing by Author "Sitges, Marta (7006509888)"
Now showing 1 - 5 of 5
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Criteria for surveys: From the European Association of Cardiovascular Imaging Scientific Initiatives Committee(2019) ;Haugaa, Kristina H. (24733615600) ;Marsan, Nina Ajmone (23035780700) ;Cameli, Matteo (36906722500) ;D'Andrea, Antonello (55612687400) ;Dweck, Marc R. (12783691400) ;Carvalho, Ricardo Fontes (57210811139) ;Holte, Espen (23024605700) ;Manka, Robert (8839069800) ;Michalski, Blazej (14527627100) ;Podlesnikar, Tomaz (57188636569) ;Popescu, Bogdan A. (37005664700) ;Schulz-Menger, Jeanette (6701382131) ;Sitges, Marta (7006509888) ;Stankovic, Ivan (57197589922) ;Maurer, Gerald (55606327600)Edvardsen, Thor (6603263370)The European Association of Cardiovascular Imaging (EACVI) is committed to maintaining the highest standards of professional excellence in all aspects of cardiovascular imaging. The mission of the EACVI is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging with a particular focus on education, training, scientific initiatives, and research. The EACVI established the Scientific Initiatives Committee (SIC) in December 2018. This committee has responsibility for surveys among imagers, patients' surveys and surveys including data from clinical practice. The current document describes the aims of the EACVI SIC and the creation of the international EACVI survey network. This document summarizes the EACVI's standards for the survey questions and standards for writing the papers with the results of the surveys. These are in accordance with previous recommendations and were approved by the EACVI SIC and the EACVI Board in 2019. © 2019 Published on behalf of the European Society of Cardiology. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication EACVI survey on the evaluation of left ventricular diastolic function(2021) ;Sitges, Marta (7006509888) ;Ajmone Marsan, Nina (23035780700) ;Cameli, Matteo (36906722500) ;D'Andrea, Antonello (55612687400) ;Carvalho, Ricardo Fontes (57210811139) ;Holte, Espen (23024605700) ;Michalski, Blazej (14527627100) ;Podlesnikar, Tomaz (57188636569) ;Popescu, Bogdan A (37005664700) ;Schulz-Menger, Jeanette (6701382131) ;Stankovic, Ivan (57197589922) ;Haugaa, Kristina H (24733615600)Dweck, Marc R (12783691400)Aims: The aim of this study is to analyse how current recommendations on left ventricular (LV) diastolic function assessment have been adopted. Identifying potential discrepancies between recommendations and everyday clinical practice would enable us to better understand and address the remaining challenges in this controversial and complex field. Methods and results: A total of 93 centres, mainly from tertiary care settings, responded to the survey. More than three-quarters (77%) of centres follow the 2016 ASE/EACVI recommendations for LV diastolic function evaluation in patients with preserved ejection fraction based upon e′, E/e′, tricuspid regurgitation velocity, and left atrial (LA) volume. These recommendations were generally preferred to the previous 2009 version. Many centres also consider strain assessments in the LV (48%) and left atrium (53%) as well as diastolic stress echocardiography (33%) to be useful as additional assessments of LV diastolic function. Echocardiographic assessments of LV diastolic function were used frequently to guide therapy in 72% of centres. Conclusion: There is widespread adoption of current recommendation on the evaluation of LV diastolic function and these are frequently used to guide patient management. Many centres now also consider LV and LA strain assessments useful in the clinical assessment of diastolic function. These may be considered in future recommendations. © 2021 The Author(s). - Some of the metrics are blocked by yourconsent settings
Publication EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation(2016) ;Donal, Erwan (7003337454) ;Lip, Gregory Y. H (57216675273) ;Galderisi, Maurizio (7005866296) ;Goette, Andreas (7003555566) ;Shah, Dipen (7402371395) ;Marwan, Mohamed (6601980795) ;Lederlin, Mathieu (23088959900) ;Mondillo, Sergio (7003927718) ;Edvardsen, Thor (6603263370) ;Sitges, Marta (7006509888) ;Grapsa, Julia (57204441798) ;Garbi, Madalina (55827839600) ;Senior, Roxy (55165129300) ;Gimelli, Alessia (6603051677) ;Potpara, Tatjana S (57216792589) ;Van Gelder, Isabelle C (7006440916) ;Gorenek, Bulent (7004714353) ;Mabo, Philippe (7007031099) ;Lancellotti, Patrizio (7003380556) ;Kuck, Karl-Heinz (35237924900) ;Popescu, Bogdan A (37005664700) ;Hindricks, Gerhard (35431335000)Habib, Gilbert (7101933258)Atrial fibrillation (AF) is the commonest cardiac rhythm disorder. Evaluation of patients with AF requires an electrocardiogram, but imaging techniques should be considered for defining management and driving treatment. The present document is an expert consensus from the European Association of Cardiovascular Imaging (EACVI) and the European Heart Rhythm Association. The clinical value of echocardiography, cardiac magnetic resonance (CMR), computed tomography (CT), and nuclear imaging in AF patients are challenged. Left atrial (LA) volume and strain in echocardiography as well as assessment of LA fibrosis in CMR are discussed. The value of CT, especially in planning interventions, is highlighted. Fourteen consensus statements have been reached. These may serve as a guide for both imagers and electrophysiologists for best selecting the imaging technique and for best interpreting its results in AF patients. © 2016 Published on behalf of the European Society of Cardiology. - Some of the metrics are blocked by yourconsent settings
Publication Rational and design of EuroCRT: An international observational study on multi-modality imaging and cardiac resynchronization therapy(2017) ;Donal, Erwan (7003337454) ;Delgado, Victoria (24172709900) ;Magne, Julien (22938314200) ;Bucciarelli-Ducci, Chiara (18534251300) ;Leclercq, Christophe (7006426549) ;Cosyns, Bernard (57202595662) ;Sitges, Marta (7006509888) ;Edvardsen, Thor (6603263370) ;Sade, Elif (59157858400) ;Stankovic, Ivan (57197589922) ;Agricola, Eustachio (7004352036) ;Galderisi, Maurizio (7005866296) ;Lancellotti, Patrizio (7003380556) ;Hernandez, Alfredo (57014110400) ;Plein, Sven (6701840061) ;Muraru, Denisa (57203383206) ;Schwammenthal, Ehud (7007108816) ;Hindricks, Gerhard (35431335000) ;Popescu, Bogdan A. (37005664700)Habib, Gilbert (7101933258)Aims: Assessment of left ventricular (LV) volumes and ejection fraction (LVEF) with cardiac imaging is important in the selection of patients for cardiac resynchronization therapy (CRT). Several observational studies have explored the role of imaging-derived LV dyssynchrony parameters to predict the response to CRT, but have yielded inconsistent results, precluding the inclusion of imaging-derived LV dyssynchrony parameters in current guidelines for selection of patients for CRT. Methods: The EuroCRT is a large European multicentre prospective observational study led by the European Association of Cardiovascular Imaging. We aim to explore if combing the value of cardiac magnetic resonance (CMR) and echocardiography could be beneficial for selecting heart failure patients for CRT in terms of improvement in long-term survival, clinical symptoms, LV function, and volumes. Speckle tracking echocardiography will be used to assess LV dyssynchrony and wasted cardiac work whereas myocardial scar will be assessed with late gadolinium contrast enhanced CMR. All data will be measured in core laboratories. The study will be conducted in European centres with known expertise in both CRT and multimodality cardiac imaging. © The Author 2017. - Some of the metrics are blocked by yourconsent settings
Publication The EACVI survey on cardiac imaging in cardio-oncology(2021) ;Stankovic, Ivan (57197589922) ;Dweck, Marc R (12783691400) ;Marsan, Nina Ajmone (23035780700) ;Bergler-Klein, Jutta (56019537300) ;Holte, Espen (23024605700) ;Manka, Robert (8839069800) ;Schulz-Menger, Jeanette (6701382131) ;Sitges, Marta (7006509888)Haugaa, Kristina H (24733615600)Early and late cardiovascular (CV) toxicities related to many cancer treatments may complicate the clinical course of patients, offsetting therapeutic benefits, and altering prognosis. The early detection, monitoring, and treatment of cardiotoxicity have therefore become essential parts of cancer patient care. CV imaging is a cornerstone of every cardio-oncology unit, but its use may vary across Europe because of the non-uniform availability of advanced imaging techniques and differences in the organization and logistics of cardio-oncology services. The purpose of this EACVI survey in cardio-oncology is to obtain real-world data on the current usage of cardiac imaging in cancer patients. Data from 104 centres and 35 different countries confirmed that cardiac imaging plays a pivotal role in the detection and monitoring of cardiac toxicity in oncology patients in Europe and beyond. However, it also revealed gaps between guidelines recommendations and everyday clinical practice, highlighting some of the challenges that need to be overcome in this rapidly advancing field. © 2020 Published on behalf of the European Society of Cardiology. All rights reserved.